SE0201373D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
SE0201373D0
SE0201373D0 SE0201373A SE0201373A SE0201373D0 SE 0201373 D0 SE0201373 D0 SE 0201373D0 SE 0201373 A SE0201373 A SE 0201373A SE 0201373 A SE0201373 A SE 0201373A SE 0201373 D0 SE0201373 D0 SE 0201373D0
Authority
SE
Sweden
Prior art keywords
combination therapy
compound
pharmaceutically
melagatran
combination product
Prior art date
Application number
SE0201373A
Other languages
English (en)
Inventor
Elisabeth Svernhage
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201373A priority Critical patent/SE0201373D0/sv
Publication of SE0201373D0 publication Critical patent/SE0201373D0/sv
Priority to TW092112174A priority patent/TW200403071A/zh
Priority to EP03721266A priority patent/EP1503782A1/en
Priority to JP2004500904A priority patent/JP2005531546A/ja
Priority to PCT/SE2003/000720 priority patent/WO2003092721A1/en
Priority to AU2003224590A priority patent/AU2003224590A1/en
Priority to PL03372368A priority patent/PL372368A1/xx
Priority to BR0309354-9A priority patent/BR0309354A/pt
Priority to MXPA04010716A priority patent/MXPA04010716A/es
Priority to KR10-2004-7017782A priority patent/KR20050007470A/ko
Priority to CA002483001A priority patent/CA2483001A1/en
Priority to RU2004129730/15A priority patent/RU2004129730A/ru
Priority to US10/513,187 priority patent/US20060074080A1/en
Priority to CNA038102129A priority patent/CN1652811A/zh
Priority to ARP030101594A priority patent/AR039572A1/es
Priority to NO20044554A priority patent/NO20044554L/no
Priority to ZA200408615A priority patent/ZA200408615B/en
Priority to IL16486904A priority patent/IL164869A0/xx
Priority to IS7561A priority patent/IS7561A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE0201373A 2002-05-06 2002-05-06 Combination therapy SE0201373D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE0201373A SE0201373D0 (sv) 2002-05-06 2002-05-06 Combination therapy
TW092112174A TW200403071A (en) 2002-05-06 2003-05-02 Combination therapy
CNA038102129A CN1652811A (zh) 2002-05-06 2003-05-05 含美拉加川和抗心率失常的oxabispidine的组合产品
MXPA04010716A MXPA04010716A (es) 2002-05-06 2003-05-05 Un producto de combinacion que comrpende melagatran y oxabispidinas antiarritmicas.
RU2004129730/15A RU2004129730A (ru) 2002-05-06 2003-05-05 Комбинированный продукт, содержащий мелагатран и антиаритмические оксадиспидины
PCT/SE2003/000720 WO2003092721A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
AU2003224590A AU2003224590A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
PL03372368A PL372368A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
BR0309354-9A BR0309354A (pt) 2002-05-06 2003-05-05 Produto combinado, conjunto de partes, métodos para fabricar um conjunto de partes e para tratar arritmia, e, usos de um produto combinado, de melagatran ou um derivado farmaceuticamente aceitável do mesmo
EP03721266A EP1503782A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
KR10-2004-7017782A KR20050007470A (ko) 2002-05-06 2003-05-05 멜라가트란 및 항부정맥 옥사비스피덴을 포함하는 조합생성물
CA002483001A CA2483001A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
JP2004500904A JP2005531546A (ja) 2002-05-06 2003-05-05 メラガトランと抗不整脈性オキサビスピジンとを含む組み合わせ製品
US10/513,187 US20060074080A1 (en) 2002-05-06 2003-05-05 Combination product comprising melagatran and an anti-arrhythmic oxabispidenes
ARP030101594A AR039572A1 (es) 2002-05-06 2003-05-06 Producto de combinacion, conjunto de elementos (kit), metodo para preparar un conjunto de elementos y el uso de dicho producto de combinacion y de dicho conjunto de elementos en la fabricacion de un medicamento
NO20044554A NO20044554L (no) 2002-05-06 2004-10-22 Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener
ZA200408615A ZA200408615B (en) 2002-05-06 2004-10-25 A combination product comprising melagatran and ananti-arrhythmic oxabispidenes
IL16486904A IL164869A0 (en) 2002-05-06 2004-10-27 A combination product comprising melagatran and anti-arrhythmic oxabispidines
IS7561A IS7561A (is) 2002-05-06 2004-11-29 Samsett afurð sem felur í sér melagatran og sláttarglapastillandi oxabispíden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201373A SE0201373D0 (sv) 2002-05-06 2002-05-06 Combination therapy

Publications (1)

Publication Number Publication Date
SE0201373D0 true SE0201373D0 (sv) 2002-05-06

Family

ID=20287788

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201373A SE0201373D0 (sv) 2002-05-06 2002-05-06 Combination therapy

Country Status (19)

Country Link
US (1) US20060074080A1 (sv)
EP (1) EP1503782A1 (sv)
JP (1) JP2005531546A (sv)
KR (1) KR20050007470A (sv)
CN (1) CN1652811A (sv)
AR (1) AR039572A1 (sv)
AU (1) AU2003224590A1 (sv)
BR (1) BR0309354A (sv)
CA (1) CA2483001A1 (sv)
IL (1) IL164869A0 (sv)
IS (1) IS7561A (sv)
MX (1) MXPA04010716A (sv)
NO (1) NO20044554L (sv)
PL (1) PL372368A1 (sv)
RU (1) RU2004129730A (sv)
SE (1) SE0201373D0 (sv)
TW (1) TW200403071A (sv)
WO (1) WO2003092721A1 (sv)
ZA (1) ZA200408615B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor

Also Published As

Publication number Publication date
BR0309354A (pt) 2005-02-15
US20060074080A1 (en) 2006-04-06
AU2003224590A1 (en) 2003-11-17
AR039572A1 (es) 2005-02-23
PL372368A1 (en) 2005-07-25
EP1503782A1 (en) 2005-02-09
JP2005531546A (ja) 2005-10-20
ZA200408615B (en) 2006-04-26
CA2483001A1 (en) 2003-11-13
KR20050007470A (ko) 2005-01-18
IS7561A (is) 2004-11-29
RU2004129730A (ru) 2005-07-10
TW200403071A (en) 2004-03-01
IL164869A0 (en) 2005-12-18
CN1652811A (zh) 2005-08-10
WO2003092721A1 (en) 2003-11-13
MXPA04010716A (es) 2005-03-07
NO20044554L (no) 2004-11-16

Similar Documents

Publication Publication Date Title
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
GB0005251D0 (en) Therapeutic compounds
PL1940786T3 (pl) Pochodne bifenylowe i ich zastosowanie w leczeniu zapalenia wątroby typu C
GB0225474D0 (en) Therapeutic agents
ATE408601T1 (de) Fredericamycin-derivate
HK1153471A1 (en) 2-(morpholin-4-yl)pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
GEP20053631B (en) ) New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
GEP20032922B (en) Benzoheterocycles and Their Use as MEK Inhibitors
BR0315337A (pt) Composto, formulação farmacêutica, e, método para tratar câncer
BRPI0512253A (pt) composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
ZA200508889B (en) Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxomorpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor Xa in the treatment of thrombo-embolic diseases
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
WO2004002477A8 (de) 2-(phenyl)-2h-pyrazol-3-carbonsäure-n-4-(thioxo-heterocyclyl)-phenyl-amid derivate und entsprechende imino-heterocyclyl derivate sowie verwandte verbindungen als inhibitoren der koagulationsfaktoren xa und/oder viia zur behandlung bon thrombosen
HK1099918A1 (en) Composition and use for prevention or treatment of stomatitis
SE0201662D0 (sv) Pharmaceutical combination
WO2004016741A3 (en) Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
GB0522908D0 (en) Therapeutic agents